News

This short video clip provides a brief insight into the experiences of Thyroid Cancer survivors. It’s part of a forthcoming film to be distributed free to all new thyroid cancer patients in the UK.

In February 2012 Astra Zeneca received approval from the European Medicines Agency for Calpresa (Vandetanib), the first and only tyrosine kinase inhibitor licensed for the treatment of aggressive and symptomatic medullary thyroid cancer (MTC) in patients with unresectable locally advanced or metastatic disease. The approval of Calpresa was based of the results of the ZETA […]

Click to read: Shoppers to be given vital cancer checks “A Wearside surgeon will be among those taking part in a series of cancer check clinics.” (Sunderland Echo, September 2011)